Navigation Links
HemaQuest Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
Date:4/25/2011

or the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.CONTACTS:

Jerome Lyons

Tamara A. SeymourOffice Manager

Chief Financial OfficerT: 206.826.9900

T: 858.356.5582jlyons@hemaquest.com

tseymour@hemaquest.com
'/>"/>

SOURCE HemaQuest Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
2. HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
3. HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , September 2, 2015 Elekta, ... on cancer survivorship on September 10, 6:30-8:30 p.m., at Elekta,s ... Elekta,s Ultimate Ride to Survivorship " will feature Professional BMX ... treatment of a brain tumor with Leksell Gamma Knife®, Elekta,s ... 48,070 new cancer cases will be diagnosed in ...
(Date:9/2/2015)... , Sept. 2, 2015 Boston Scientific Corporation ... 2015 Morgan Stanley Global Healthcare Conference on September 17, in ... Mike Mahoney , chief executive officer, and Dan Brennan ... in a 30-minute question and answer session regarding the company ... A live webcast of the question and answer ...
(Date:9/2/2015)... Quebec , Sept. 2, 2015  Valeant Pharmaceuticals ... today announced that its affiliate has entered into a ... USA , Inc. (NASDAQ: SURG ) ... the upfront cash payment, Synergetics stockholders will receive additional ... specified sales milestones are achieved following the closing.  The ...
Breaking Medicine Technology:Elekta to Host Cancer Survivorship Event at Company's Learning and Innovation Center (LINC) in Atlanta 2Elekta to Host Cancer Survivorship Event at Company's Learning and Innovation Center (LINC) in Atlanta 3Boston Scientific To Participate In 2015 Morgan Stanley Global Healthcare Conference 2Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5
... Spain, Feb. 18, 2011 Grifols, the Spanish group which ... world,s leading producers of plasma products, will shortly start construction ... euros that will employ about 100 people, as soon as ... have the capacity to fractionate 1 million liters of plasma ...
... At this week,s annual meeting of the ... SNN, LSE: SN) Orthopaedic Division introduced its Short Modular ... stem system that exceeds the versatility and neck strength ... the stability of the traditionally longer, more invasive implant. ...
Cached Medicine Technology:Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles) 2Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem 2Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem 3Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem 4
(Date:9/2/2015)... ... ... to an article published August 12 by International Business Times, a new bill ... grand juries in cases meant to decide if a police officer used deadly or excessive ... in Ferguson and New York City that absolved police officers of charges in the deaths ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... from the Abraham and Mildred Goldstein Charitable Trust to establish the Abraham and ... gift comes six months after WCHN recruited nationally known gynecologic oncologist Thomas J. ...
(Date:9/2/2015)... Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... featured by the Huffington Post on August 25th, writer Akela Stanfield detailed her ... surgery. While the author acknowledged that she had always seen herself as someone who ...
(Date:9/2/2015)... Covington, LA (PRWEB) , ... September 02, 2015 ... ... new President/CEO and Regulatory Affairs Officer following the departure of Kristen Dietz, former ... Medical Officer of Healtec® released the following statement welcoming Mr. Salot: “ Stanley ...
(Date:9/2/2015)... ... 02, 2015 , ... Density measurement is used in many ... handling makes density measurements more efficient and error-free. The new METTLER TOLEDO video ... and the advantages compared to manual sample handling. , The Evolution of Density ...
Breaking Medicine News(10 mins):Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:Healtec® Announces Executive Leadership Change 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3
... , Front-line Caregivers, Nursing Home Residents and Their Family ... Delegation to Stop Potential Cuts , , ... , , RIO RANCHO, N.M., Aug. 11 A ... nursing home residents and their family members to sign a petition that will ...
... , , WELLESLEY HILLS, Mass., ... the PRX-07034 Therapeutics - CNS Phase 2 will be part of the ... , , The PRX-07034 Therapeutics - CNS Phase 2 ... schizophrenia (CIAS). The Company has completed Phase 1 in obesity with ...
... exercise capacity in some mountaineers, according to Swiss researchers. ... been used for years to treat altitude-related symptoms in ... to improve exercise capacity at high altitude. "We ... for preventing high altitude pulmonary edema (HAPE) and dex ...
... It doesn,t affect quality of life in most cases, review ... spares the limbs of some cancer patients may have little ... cost or quality of life, researchers say. , Limb-sparing ... bone or soft-tissue sarcomas, but the analysis by Canadian researchers ...
... Pain therapy for cancer patients whether inpatient or ... the use of an innovative electronic system combined ... been successfully tested. The treatment of the patients showed ... addition, patients reported having less pain. The results of ...
... delivery for older adults developed by researchers from Indiana ... of life, decreased emergency department visits and lowered hospital ... saved money for the sickest (those with three to ... year after the home-based intervention ended, it saved even ...
Cached Medicine News:Health News:New Mexico Seniors to Lose $130.2 Million in Medicare Long Term Care Funding in House Healthcare Reform Bill 2Health News:Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction 2Health News:Taking dex can improve high altitude exercise capacity in certain climbers 2Health News:Taking dex can improve high altitude exercise capacity in certain climbers 3Health News:Limb-Sparing Surgery May Offer Little Benefit to Cancer Patients 2Health News:Computer system improves pain therapy for cancer patients 2Health News:Aging with GRACE: New health care delivery model improves outcomes, saves money 2Health News:Aging with GRACE: New health care delivery model improves outcomes, saves money 3